I'rom Group Co., Ltd. (2372)’in fiyatı nedir?

I'rom Group Co., Ltd. (2372)’in fiyatı $18.20’dir

I'rom Group Co., Ltd. (2372)’in piyasa değeri nedir?

I'rom Group Co., Ltd. (2372)’in piyasa değeri $220.35M’dir.

I'rom Group Co., Ltd. (2372) Tedavüldeki Hisseler

I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.

Yıl	Tedavüldeki Hisse Sayısı	Değiştir
2026 (TTM)	12.11M	-0.02%
2024	12.11M	0.11%
2023	12.09M	0.19%
2022	12.07M	0.45%
2021	12.02M	2.87%
2020	11.68M	0.23%
2019	11.66M	1.23%
2018	11.51M	5.84%
2017	10.88M	2.51%
2016	10.61M	3.46%
2015	10.26M	7.29%
2014	9.56M	2.23%
2013	9.35M	0.00%
2012	9.35M	0.00%
2011	9.35M	0.00%
2010	9.35M	0.00%
2009	9.35M	0.00%
2008	9.35M	0.13%
2007	9.34M	0.69%
2006	9.28M	11.44%
2005	8.32M	0.00%

Yıl

Tedavüldeki Hisse Sayısı

Değiştir

2026 (TTM)

12.11M

-0.02%

2024

12.11M

0.11%

2023

12.09M

0.19%

2022

12.07M

0.45%

2021

12.02M

2.87%

2020

11.68M

0.23%

2019

11.66M

1.23%

2018

11.51M

5.84%

2017

10.88M

2.51%

2016

10.61M

3.46%

2015

10.26M

7.29%

2014

9.56M

2.23%

2013

9.35M

0.00%

2012

9.35M

0.00%

2011

9.35M

0.00%

2010

9.35M

0.00%

2009

9.35M

0.00%

2008

9.35M

0.13%

2007

9.34M

0.69%

2006

9.28M

11.44%

2005

8.32M

0.00%

Şirket	Tedavüldeki Hisse Sayısı	Fark	Ülke
HCA Healthcare, Inc. HCA.US	222.83M	1,740.71%	US
Fresenius SE & Co. KGaA FRE.DE	-	-	DE
Dr. Sulaiman Al Habib Medical Services Group Company 4013.SR	350.00M	2,791.26%	SA
Tenet Healthcare Corporation THC.US	83.52M	589.96%	US
IHH Healthcare Berhad 5225.KL	-	-	MY

Şirket

Tedavüldeki Hisse Sayısı

Fark

Ülke